Kathy Yi

Kathy Yi

Chief Operating Officer at
Affini-T Therapeutics, Inc.
54 year
Health Technology
Commercial Services
Consumer Services

Profile

Kathy Yi is on the board of Sangamo Therapeutics UK Ltd. and Theseus Pharmaceuticals, Inc. In the past Ms. Yi held the position of CFO, Secretary, Principal Accounting Officer & EVP at Sangamo Therapeutics, Inc., Chief Financial Officer at Cerevel Therapeutics Holdings, Inc., Director-Finance & Corporate Development at Life Technologies Corp. and Head-Finance, Inhalation Technical R&D at Novartis Pharmaceuticals Corp. She received an undergraduate degree from the University of California, Berkeley and an MBA from Columbia Business School.

Kathy Yi active positions

CompaniesPositionStart
Director/Board Member 2017-02-27
Chief Operating Officer -

Former positions of Kathy Yi

CompaniesPositionEnd
THESEUS PHARMACEUTICALS, INC. Director/Board Member 2024-02-13
CEREVEL THERAPEUTICS HOLDINGS, INC. Director of Finance/CFO 2021-09-19
SANGAMO THERAPEUTICS, INC. Director of Finance/CFO 2019-06-06
Director of Finance/CFO 2013-12-31
Corporate Officer/Principal -
See the detail of Kathy Yi's experience

Training of Kathy Yi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology